Aspira Women's Health Regained Compliance With Nasdaq's Minimum Bid Price Requirement
Portfolio Pulse from Benzinga Newsdesk
Aspira Women's Health has regained compliance with Nasdaq's minimum bid price requirement, ensuring the company remains listed on the stock exchange.

June 02, 2023 | 12:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Aspira Women's Health's stock may see a positive short-term impact as the company regains compliance with Nasdaq's minimum bid price requirement.
Aspira Women's Health regaining compliance with Nasdaq's minimum bid price requirement ensures the company remains listed on the stock exchange. This news is likely to be seen as positive by investors, potentially leading to a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100